Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Fritzen K
  • Basinska K
  • Stautner C
  • Braun KF
  • Nicolucci A
  • Kennon B
  • Vergès B
  • Hosny Y
  • Schnell O

Grupos

Abstract

Costs for the treatment of diabetes and its comorbidities are a major international issue. A recent randomized clinical trial showed that the introduction of color range indicator (CRI)-based glucose meters (GMs) positively affects the HbA1c of patients with type 1 and type 2 diabetes, when compared to GMs without a CRI. This budget impact analysis aimed to translate this beneficial effect of CRI-based GMs, OneTouch Verio Flex and OneTouch Verio, into potential monetary impact for the healthcare systems of five European countries, Germany, Spain, Italy, France, and the United Kingdom.

Datos de la publicación

ISSN/ISSNe:
1932-2968, 1932-2968

Journal of Diabetes Science and Technology  SAGE PUBLICATIONS INC

Tipo:
Article
Páginas:
262-270
PubMed:
31387385
Factor de Impacto:
1,039 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 2

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • budget impact analysis, color range indicator, diabetes mellitus, economic analysis, glucose meter, monitoring

Cita

Compartir